Search clinical trials for: Tamsulosin Hydrochloride Placebo

Total 59917 results

Boehringer Ingelheim

Completed

Pharmacokinetics, Safety and Tolerability of Tamsulosin Hydrochloride in Children With Voiding Disorders

Urination Disorders
Astellas Pharma Europe B.V.

Completed

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms (Neptune)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
Lawson Health Research Institute

Not yet recruiting

Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial (PrePOURTS)

Urinary Retention Postoperative

Canada
McMaster University

Not yet recruiting

REduction of Post-Operative Urinary Retention With Tamsulosin Versus Placebo (REPOURT- P) Trial (REPOURT-P)

Thoracic Surgery | Thoracic Epidural Analgesia | Urinary Catheterization
National Institute of Diabetes and Digestive and...

Completed

Chronic Prostatitis Collaborative Research Network Clinical Trial- Ciprofloxacin and Tamsulosin (CPCRN RCT1)

Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Pierre Fabre Medicament

Completed

PERmixon® in LUTS Evaluation Study (PERLES) (PERLES)

Benign Prostatic Hyperplasia (BPH)

France, Italy, Germany, Spain, Czech Republic
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

Benign Prostate Hyperplasia

Korea, Republic of
Boehringer Ingelheim

Completed

Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms

Lower Urinary Tract Symptoms
Boehringer Ingelheim

Completed

FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)

Prostate Hyperplasia
Pontificia Universidad Catolica de Chile

Terminated

Tamsulosin as Adjuvant Treatment Prior to Endoscopic Ureterolithotomy

Urolithiasis | Ureteral Calculi | Ureterolithiasis

Chile
Boehringer Ingelheim

Completed

Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

Bladder, Neurogenic

Belgium, Spain, United States, India, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, Brazil, Mexico, Ukraine
CHU de Quebec-Universite Laval

Recruiting

Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery (TEMPOUR)

Urinary Retention

Canada
Astellas Pharma Inc

Completed

Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction

Lower Urinary Tract Symptoms | Bladder Outlet Obstruction

United States, Czech Republic, Poland, Hungary, Belgium, Germany
ChaingMai University

Unknown

Efficacy of Tamsulosin Oral-controlled Absorption System (OCAS) in the Treatment of Distal Ureteral Stones

Ureteral Calculi

Thailand
CHU de Quebec-Universite Laval
Fédération des médecins résidents du Québec

Not yet recruiting

Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection (R-POUR)

Colorectal Surgery | Urinary Retention | Post-operative Urinary Retention | Rectal Resection | Tamsulosin

Canada
Mayo Clinic

Terminated

Use of Tamsulosin to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

Postoperative Urinary Retention

United States
Feiran Lou
UMass Memorial Health Care

Recruiting

Post-Operative Urinary Retention (POUR) in Thoracic Surgery Patients Receiving Prophylactic Tamsulosin (POUR)

Thoracic Diseases | Urinary Retention

United States
Boehringer Ingelheim

Completed

PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder

Bladder, Neurogenic

Belgium, Spain, United States, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, India, Brazil, Canada, Mexico, Ukraine
Astellas Pharma Inc

Completed

A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH (SATURN)

Lower Urinary Tract Symptoms | Prostatic Hyperplasia

France, Poland, Germany, Spain, Finland, Netherlands, Russian Federation, Czech Republic, Hungary, Norway, Denmark, Slovakia, Sweden, Austria, Portugal, United Kingdom
Pierre Fabre Medicament

Completed

Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia) (PERMIN)

Benign Prostatic Hyperplasia (BPH)

France, Spain, Portugal, Italy
GlaxoSmithKline

Completed

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. (ARI114694)

Prostatic Hyperplasia

Australia
Kocatepe University

Completed

The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil

Benign Prostatic Hyperplasia | Choroid Disease | Pupil Anomaly
Boehringer Ingelheim

Completed

Actual Use Study of Tamsulosin in Men

Urological Manifestations

United States
Timothy Boone, MD, PhD
Astellas Pharma US, Inc.

Completed

Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms (LUTS)

Lower Urinary Tract Symptoms

United States
REMD Medical Technology
RenJi Hospital; Tongji Hospital; Qilu Hospital of Shandong University; Sun Yat-Sen... and other collaborators

Completed

Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

China
Astellas Pharma Europe B.V.

Completed

Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms (Neptune II)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Poland, Slovakia, Belarus, Germany, Czechia
Xintian Pharmaceutical

Completed

Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis

China
Boehringer Ingelheim

Completed

Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
IlDong Pharmaceutical Co Ltd

Unknown

The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction

Benign Prostatic Hyperplasia | Erectile Dysfunction

Korea, Republic of
The Cleveland Clinic

Active, not recruiting

Preoperative Tamsulosin to Prevent Postoperative Urinary Retention After Surgery For Pelvic Floor Disorders

Urinary Retention

United States
Boehringer Ingelheim

Completed

Study to Assess the Bioequivalence of Two Batches of Tamsulosin Hydrochloride in Healthy Male Subjects

Healthy
Boehringer Ingelheim

Completed

FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Shenyang Sunshine Pharmaceutical Co., LTD.

Unknown

A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet

Uremic Pruritus

China
NeoTract, Inc.

Recruiting

Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH (IMPACT)

BPH

United States
Gundersen Lutheran Medical Foundation

Unknown

Daily Versus Twice Per Day Tamsulosin for Ureteral Stent Symptoms

Ureteral Diseases

United States
Assiut University

Unknown

The Use of Tamsulosin in Treatment of (10-15 mm) Lower Ureteric Stones in Adults With Non-emergent Symptoms

Ureteric Stone
Samsung Medical Center

Unknown

Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mg

Benign Prostatic Hyperplasia

Korea, Republic of
Astellas Pharma Global Development, Inc.

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) (PLUS)

Overactive Bladder | Benign Prostatic Hyperplasia

United States, Canada, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom
Assistance Publique - Hôpitaux de Paris

Terminated

Tamsulosin for Urinary Retention in Hospitalized Older Women (TAMSU)

Urinary Retention

France
Astellas Pharma Inc

Completed

Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia

Overactive Bladder | Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy

Japan
Andrew Meltzer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Tamsulosin for Urolithiasis in the Emergency Dept (STONE)

Ureterolithiases

United States
Astellas Pharma Inc
Boehringer Ingelheim; Astellas Pharma Europe Ltd.

Completed

A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.

Benign Prostatic Hyperplasia
Xijing Hospital of Digestive Diseases

Completed

A Research of Berberine Hydrochloride to Prevent Colorectal Adenomas in Patients With Previous Colorectal Cancer

Colorectal Adenomas

China
Menoufia University

Completed

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

Prostatic Neoplasms | Prostate Disease | Prostate Hypertrophy | Prostate Obstruction

Egypt
Boehringer Ingelheim

Completed

Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.

Prostatic Hyperplasia
Andrew Moshfeghi, MD, MBA
Case Western Reserve University

Withdrawn

Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DME

Diabetic Macular Edema
VA Office of Research and Development

Completed

Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS

Benign Prostatic Hyperplasia | Lower Urinary Track Symptoms

United States
Hackensack Meridian Health

Recruiting

Post-operative Urinary Retention (POUR) Following Thoracic Surgery (POUR)

Urinary Retention

United States
Astellas Pharma China, Inc.

Completed

A Study to Compare How Tamsulosin is Absorbed to the Body After Administration of Two Types of Tamsulosin Formulation Under Fed and Fasted Conditions in Chinese Healthy Subjects

Healthy | Pharmacokinetics of Tamsulosin Hydrochloride

China
Eicos Sciences, Inc.

Completed

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)

Raynaud Phenomenon Secondary to Systemic Sclerosis

United States

3

Subscribe